Cargando…

Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study

Chlorprothixene is commonly used off‐label in low doses for sedative‐hypnotic purposes although it might carry a risk of cardiometabolic adverse events due to its pharmacodynamic profile. We investigated the risk of diabetes and major adverse cardiovascular events (MACE) with use of low‐dose chlorpr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Højlund, Mikkel, Wagner, Christina Blanner, Wesselhoeft, Rikke, Andersen, Kjeld, Fink‐Jensen, Anders, Hallas, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303779/ https://www.ncbi.nlm.nih.gov/pubmed/35122399 http://dx.doi.org/10.1111/bcpt.13711

Ejemplares similares

Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels
por: Højlund, Mikkel, et al.
Publicado: (2022)

Association of Low-Dose Quetiapine and Diabetes
por: Højlund, Mikkel, et al.
Publicado: (2021)

Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions
por: Kristensen, Kasper Bruun, et al.
Publicado: (2022)

Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database
por: Thillard, Eve-Marie, et al.
Publicado: (2020)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

Experiences of becoming widowed in old age – a cross-countries study with qualitative interviews from Denmark and quantitative measures of association in a Swedish sample
por: Blanner, Christina, et al.
Publicado: (2021)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020)

Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
por: Hahn, Jongsung, et al.
Publicado: (2022)

Lithium and the risk of chronic kidney disease: A population‐based case–control study
por: Højlund, Mikkel, et al.
Publicado: (2022)

Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities
por: Kurita, Jun-ichi, et al.
Publicado: (2018)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
por: Rosli, Rosliana, et al.
Publicado: (2017)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Katsuno, Hayato, et al.
Publicado: (2021)

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
por: Guo, Haoning, et al.
Publicado: (2022)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
por: Ma, Pan, et al.
Publicado: (2022)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
por: Guo, Qiang, et al.
Publicado: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
por: Guo, Haoning, et al.
Publicado: (2022)

Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents
por: Bibi, Salma, et al.
Publicado: (2022)

Variation in adverse drug events of opioids in the United States
por: Liu, Edward Y., et al.
Publicado: (2023)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
por: Jiao, Xue-Feng, et al.
Publicado: (2023)

Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020
por: Højlund, Mikkel, et al.
Publicado: (2022)

Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta−analysis
por: Yuan, Rong, et al.
Publicado: (2022)

Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study
por: Vieira, Jean Mendes de Lucena, et al.
Publicado: (2020)

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019)

Current landscape and tailored management of immune-related adverse events
por: Liu, Wenhui, et al.
Publicado: (2023)

Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study
por: Kildegaard, Helene, et al.
Publicado: (2022)

Widowhood and mortality: a Danish nationwide register-based cohort study
por: Blanner, C., et al.
Publicado: (2020)

Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System
por: Yang, Renjun, et al.
Publicado: (2022)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system
por: Onda, Kenji, et al.
Publicado: (2023)

Use of ADHD Medication Among Danish Children and Adolescents from 2010-2020 - A Nationwide Study
por: Stoltz-Andersen, M., et al.
Publicado: (2022)

Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
por: Wakabayashi, Tomohito, et al.
Publicado: (2022)

β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012)

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study
por: Lødrup, Anders, et al.
Publicado: (2014)

Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
por: Tan, Yu, et al.
Publicado: (2021)

Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7m4c8ivrsno3vqmhdlpm1s69h8